I understand your concern, however I believe the blue sky potential is more aligned (medically) with 2591 than Trof. For many years now Neuren have been very positive about both these drugs, but IMO even moreso with 2591.
I feel the potential for Trof has been realised, with no other major avenues of treatment to pursue - however the story of 2591 is just beginning - both medically and financially.
- Forums
- ASX - By Stock
- NEU
- Ann: Q2 2023 quarterly activity and cash flow report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.29%
!
$15.39

Ann: Q2 2023 quarterly activity and cash flow report, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.39 |
Change
-0.360(2.29%) |
Mkt cap ! $1.938B |
Open | High | Low | Value | Volume |
$15.80 | $15.80 | $15.19 | $6.795M | 439.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2167 | $15.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.45 | 1494 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2167 | 15.360 |
1 | 1019 | 15.340 |
3 | 2681 | 15.320 |
1 | 9418 | 15.300 |
1 | 4 | 15.280 |
Price($) | Vol. | No. |
---|---|---|
15.450 | 1494 | 2 |
15.480 | 2948 | 3 |
15.510 | 500 | 1 |
15.540 | 704 | 1 |
15.550 | 5255 | 1 |
Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |